Description
SPRINGER Blood And Marrow Transplant Handbook Comprehensive Guide For Patient Care 3Ed (Pb 2021) by MAZIARZ R T
This updated and expanded edition developed by the Blood and Marrow Stem Cell Transplant team at Oregon Health & Science University Knight Cancer Institute features the latest medical management guidelines and standards of care for hematopoietic stem cell transplant and cellular therapy patients. _x000D__x000D_Spanning the timeline from the initial consultation throughout the transplant process, this handbook begins by providing a general overview of stem cell transplantation and goes on to outline disease-specific indications for stem cell transplantation. It then focuses on transplant complications and ongoing care, and finally explores cellular therapies for hematologic malignancies._x000D__x000D_Comprehensive and easy-to-use, Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care, Third Edition presents a multidisciplinary approach to information for physicians and advanced practice medical providers as well as residents, fellows, and other trainees who care for patients who undergo transplant and immune effector cell therapy._x000D_ _x000D_
Overview of Hematopoietic Stem Cell Transplantation & Cellular Therapy_x000D_
_x000D_
The Business of Cellular Therapy and Hematopoietic Stem Cell Transplantation_x000D_
_x000D_
Hematopoietic Stem Cell Sources and Donor Selection_x000D_
_x000D_
Pre-transplant Assessment for Hematopoietic Stem Cell Transplantation Recipients and Donors_x000D_
_x000D_
Social Work: Evaluation and Social Supports_x000D_
_x000D_
Conditioning Regimens_x000D_
_x000D_
Nutrition_x000D_
_x000D_
Physical and Occupational Therapy_x000D_
_x000D_
Adolescent and Young Adult Concerns_x000D_
_x000D_
Infection Prevention and Prophylaxis_x000D_
_x000D_
Graft-versus-Host Disease (GvHD) Prophylaxis _x000D_
_x000D_
Transfusion Medicine_x000D_
_x000D_
Anticoagulation and Antiplatelet Guidelines_x000D_
_x000D_
Engraftment_x000D_
_x000D_
Acute Myeloid Leukemia and Allogeneic Hematopoietic Stem Cell Transplant _x000D_
_x000D_
Acute Lymphoblastic Leukemia_x000D_
_x000D_
Hodgkin Lymphoma and non-Hodgkin Lymphoma_x000D_
_x000D_
Multiple Myeloma_x000D_
_x000D_
HSCT for Germ Cell Tumors_x000D_
_x000D_
Hematopoietic Stem Cell Transplant for Myelofibrosis_x000D_
_x000D_
Chronic Myeloid Leukemia_x000D_
_x000D_
Chronic Lymphocytic Leukemia_x000D_
_x000D_
Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia_x000D_
_x000D_
Inherited Disorders_x000D_
_x000D_
Hematopoietic Cell Transplant and Cellular Therapies for Sickle Cell Disease_x000D_
_x000D_
Radiology Pearls for the Transplant Provider_x000D_
_x000D_
Acute Graft-Versus-Host Disease (GvHD)_x000D_
_x000D_
Chronic Graft-versus-Host Disease_x000D_
_x000D_
Immune Reconstitution_x000D_
_x000D_
Infectious Complications _x000D_
_x000D_
Oral Complications_x000D_
_x000D_
Gastrointestinal Complications_x000D_
_x000D_
Pulmonary Complications_x000D_
_x000D_
Cardiovascular Complications_x000D_
_x000D_
Kidney Disease in Hematopoietic Stem Cell Transplantation_x000D_
_x000D_
Neurological Complications_x000D_
_x000D_
Endocrine Complications following Hematopoietic Stem Cell Transplantation_x000D_
_x000D_
Thrombotic Microangiopathies_x000D_
_x000D_
Women's Health Care_x000D_
_x000D_
Men's Health for Bone Marrow Transplant Patients_x000D_
_x000D_
Psychiatric Complications_x000D_
_x000D_
Graft Failure_x000D_
_x000D_
Second Primary Malignancies _x000D_
_x000D_
Relapse after Hematopoietic Stem Cell Transplantation_x000D_
_x000D_
Safe Pain Management with Opioids in Post-Transplant Patients_x000D_
_x000D_
Complementary Medicine: Acupuncture_x000D_
_x000D_
Complementary Medicine_x000D_
_x000D_
Complementary Medicine: Cannabinoids and the Hematopoietic Stem Cell Transplant (HSCT) Recipient_x000D_
_x000D_
Management of Neurocognitive Effects and Fatigue During and After Stem Cell Transplant_x000D_
_x000D_
Palliative Care_x000D_
_x000D_
Long-Term Follow Up and Survivorship_x000D_
_x000D_
CAR T Cells for Hematologic Malignancies_x000D_
_x000D_
Natural Killer Cell Therapy in Allogeneic Stem Cell Transplant _x000D_
_x000D_
Mesenchymal stromal cells: Impact on hematopoietic cell transplantation_x000D_
_x000D_
T cell Therapeutics: Donor Lymphocyte Infusion, Cytotoxic T Lymphocyte Infusion and Other Non-CAR T cell Therapies_x000D_
_x000D_
Dendritic Cell Vaccines_x000D_
_x000D_
BiTEs, DARTs and Peri-Transplant Minimal Residual Disease_x000D_
_x000D_
CAR T Toxicity Management: Cytokine Release Syndrome and Neurotoxicity_x000D_
_x000D_
Molecular testing for post-transplant surveillance _x000D_
_x000D_
Management of Immune Compromised Transplant and Immune Effector Cell Treated Patients in the Setting of the COVID-19 Viral Pandemic: the OHSU Experience_x000D_
_x000D_
Appendix 1: The Vocabulary of Transplant_x000D_
_x000D_
Appendix 2: Procedure - Bone Marrow Aspirate and Biopsy _x000D_
_x000D_
Appendix 3: Procedure - Lumbar Puncture _x000D_
_x000D_
Appendix 4: Procedure - Ommaya reservoir tap_x000D_
_x000D_
Appendix 5: Procedure - Skin Biopsy _x000D_
_x000D_
Appendix 6: OHSU Food Safe Diet_x000D_
_x000D_
Appendix 7: OHSU Low Bacteria Diet_x000D_
_x000D_
Appendix 8: OHSU's Graft-versus-host disease diet_x000D_
_x000D_
Appendix 9: OHSU vaccine guidelines_x000D_
_x000D_
Appendix 10: OHSU Donor and stem cell source selection in allogeneic hematopoietic progenitor cell transplantation_x000D_